Development of sarcoidosis following etanercept treatment: a report of three cases

被引：20

作者：

Skoie, Inger Marie ^{[1
]}

Wildhagen, Klaus ^{[1
]}

Omdal, Roald ^{[1
]}

机构：

[1] Stavanger Univ Hosp, Clin Immunol Unit, Dept Internal Med, N-4068 Stavanger, Norway

来源：

RHEUMATOLOGY INTERNATIONAL | 2012年 / 32卷 / 04期

关键词：

Tumor necrosis factor-alpha inhibitors; Sarcoidosis; Cytokines; T regulatory cells; TUMOR-NECROSIS-FACTOR; PLACEBO-CONTROLLED TRIAL; PULMONARY SARCOIDOSIS; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; INFLIXIMAB THERAPY; FACTOR ANTAGONISTS; FACTOR-ALPHA; INFECTION; GRANULOMA;

D O I：

10.1007/s00296-009-1349-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

After over 10 years of use of tumor necrosis factor-alpha (TNF-alpha) inhibitors, their side effects and complications are reasonably well documented. Recently, however, granulomatous reactions and cases of complete sarcoidosis have been reported, especially in patients treated with the TNF-alpha receptor protein, etanercept. This is intriguing because the TNF-alpha antibody drugs infliximab and adalimumab are reportedly used to treat sarcoidosis. We present three patients who developed sarcoidosis while on etanercept treatment, and discuss if possible differences in cytokine profiles and T regulatory cell function in patients taking different TNF-alpha inhibitors may explain this paradox.

引用

页码：1049 / 1053

页数：5

共 50 条

[1] Development of sarcoidosis following etanercept treatment: a report of three cases
Inger Marie Skoie
Klaus Wildhagen
Roald Omdal
Rheumatology International, 2012, 32 : 1049 - 1053
[2] Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept
Horta Barbosa Vieira, Marcella Amaral
Ramos Saraiva, Maria Isabel
Leite da Silva, Larissa Karine
Fraga, Rafael Cavanellas
Kakizaki, Priscila
Sakai Valente, Neusa Yuriko
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (08): : 718 - 720
[3] Pulmonary sarcoidosis developing during treatment with etanercept
Kerjouan, M.
Jouneau, S.
Lena, H.
Luraine, R.
Desrues, B.
Delaval, P.
REVUE DES MALADIES RESPIRATOIRES, 2011, 28 (03) : 360 - 364
[4] Bullous sarcoidosis - A report of three cases
Judson, MA
Strange, C
CHEST, 1998, 114 (05) : 1474 - 1478
[5] Development of sarcoidosis during etanercept therapy
Ishiguro, Takashi
Takayanagi, Noboru
Kurashima, Kazuyoshi
Matsushita, Aya
Harasawa, Keiji
Yoneda, Koichiro
Tsuchiya, Noriko
Miyahara, Yousuke
Yamaguchi, Shozaburo
Yano, Ryozo
Tokunaga, Daidou
Saito, Hiroo
Ubukata, Mikio
Yanagisawa, Tsutomu
Sugita, Yutaka
Kawabata, Yoshinori
INTERNAL MEDICINE, 2008, 47 (11) : 1021 - 1025
[6] Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients
Verschueren, Kilian
Van Essche, Els
Verschueren, Patrick
Taelman, Veerle
Westhovens, Rene
CLINICAL RHEUMATOLOGY, 2007, 26 (11) : 1969 - 1971
[7] Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients
Kilian Verschueren
Els Van Essche
Patrick Verschueren
Veerle Taelman
Rene Westhovens
Clinical Rheumatology, 2007, 26 : 1969 - 1971
[8] Renal manifestations of sarcoidosis. Report of three cases
Peces, R
Laures, AS
Navascues, RA
Baltar, J
Seco, M
Ortega, F
Marin, R
Grande, JA
NEFROLOGIA, 1998, 18 (02): : 161 - 164
[9] SARCOIDOSIS DURING ETANERCEPT TREATMENT FOR RHEUMATOID ARTHRITIS IN WOMEN WITH A HISTORY OF BILATERAL OOPHORECTOMY
Sawahata, Michiru
Sugiyama, Yukihiko
Yamasawa, Hideaki
Miki, Atsushi
Yamamoto, Hisashi
Muto, Shigeaki
Yamamoto, Hironori
Bando, Masashi
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2016, 33 (02) : 178 - 181
[10] Systemic sarcoidosis induced by etanercept: first Brazilian case report
Unterstell, Natasha
Bressan, Aline Lopes
Serpa, Laura Araujo
da Fonseca e Castro, Perola Peres
Gripp, Alexandre Carlos
ANAIS BRASILEIROS DE DERMATOLOGIA, 2013, 88 (06) : 197 - 199

← 1 2 3 4 5 →